Economic Evaluation Of Axitinib For Second Line Treatment In Adult Patients With Advanced Renal Cell Carcinoma - The Portuguese Case
AuthID
P-00A-72S
P-00A-72S
© 2025 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service